August 10, 2005
Quest Diagnostics Inc., the nation's leading provider of diagnostic testing, reaches a definitive agreement to acquire LabOne, Inc. for $934 million.
On August 8, it was announced that Lyndhurst, N.J.-based Quest Diagnostics Inc., the nation's leading provider of diagnostic testing, reached a definitive agreement to acquire LabOne, Inc. for $934 million. Quest will pay $43.90 per share of LabOne and will assume LabOne’s $132 million debt. Willkie represented Merrill Lynch & Co., financial advisor to Quest, in this transaction. Based in Lenexa, Kansas, LabOne provides health screening and risk assessment services to life insurance companies, as well as clinical diagnostic testing services to healthcare providers. The deal was handled by partner Steven Seidman and associates Laura Delanoy and Margaret Mansouri.
